- Citations, last 5 years
- 73.1k
- Works, last 5 years
- 9 238
- h-index
- 489
- Scientists listed
- 425
- Grants since 2016
- 246
Grants received
2016–2018 · research · R21
Osteolytic Conversion of Inflammatory Macrophages
Yasuyoshi Ueki · University of Missouri–Kansas City · funded by National Institutes of Health
2016–2018 · research · R01
Mechanism of bone resorption in periodontitis
Yasuyoshi Ueki · University of Missouri–Kansas City · funded by National Institutes of Health
2016–2018 · research · R21
Phased Exploratory Clinical Studies of Harpagophytum procumbens’ Impact upon the Biological Signature of Inflammatory Osteoarthritis
William Robert Folk · University of Missouri–Kansas City · funded by National Institutes of Health
2016–2017 · grant · S10
Leica TCS Sp8 MP Multiphoton Microscope
Sarah L Dallas · University of Missouri–Kansas City · funded by National Institutes of Health
2016 · fellowship · Young Investigator
BBRF Young Investigator (2016) - Seung Suk Kang
Seung Suk Kang · University of Missouri–Kansas City · funded by Brain and Behavior Research Foundation
2016–2017 · grant · Standard Grant
DCL: NSF INCLUDES: Accelerating Data-Driven Collaboration for Large-Scale Progress
Alexis Petri · University of Missouri–Kansas City · funded by National Science Foundation
2016–2020 · research · R15
Role of Circadian Clock Components in Apoptosis and Tauopathy in Drosophila
Jeffrey L Price · University of Missouri–Kansas City · funded by National Institutes of Health
2016–2018 · research · R21
Phased Exploratory Clinical Studies of Harpagophytum procumbens’ Impact upon the Biological Signature of Inflammatory Osteoarthritis
William Robert Folk · University of Missouri–Kansas City · funded by National Institutes of Health
2016–2021 · grant · Standard Grant
SHF: Small: Exploiting the Negative Capacitance in a new Ferroelectric Device to Explore Innovative Design Solutions beyond the Fundamental Thermionic Limit of CMOS Technology
Masud Chowdhury · University of Missouri–Kansas City · funded by National Science Foundation
2016–2017 · grant · Standard Grant
I-Corps: Child Tracking and Detection - A Public Safety Application Through Mobile Crowd-Sensing
Baek-Young Choi · University of Missouri–Kansas City · funded by National Science Foundation
2016–2018 · grant · Standard Grant
Mathematical Models to Study the Effects of Drugs of Abuse on HIV Infection and Neurocognitive Disorder
Naveen Vaidya · University of Missouri–Kansas City · funded by National Science Foundation
2016–2019 · grant · Standard Grant
II-NEW: Experimental Characterization and CAD Development Testbed for Nanoscale Integrated Circuits
Masud Chowdhury · University of Missouri–Kansas City · funded by National Science Foundation
2016–2019 · research · R21
Multiplexed antibacterial library screening
William G Gutheil · University of Missouri–Kansas City · funded by National Institutes of Health
2016–2021 · research · R01
Mechanism of bone resorption in periodontitis
Yasuyoshi Ueki · University of Missouri–Kansas City · funded by National Institutes of Health
2015–2020 · grant · Continuing Grant
Collaborative Proposal to Examine the Function and
Leonard Dobens · University of Missouri–Kansas City · funded by National Science Foundation
2015–2021 · grant · Global Growth & Opportunity
University of Missouri - Kansas City - To support the design, analysis, build and testing of viscous heating technology units which can be used to deactivate soil-transmitted parasites f...
University of Missouri–Kansas City · funded by Bill and Melinda Gates Foundation
2015–2020 · grant · Standard Grant
TWC: TTP Option: Small: Collaborative: SRN: On Establishing Secure and Resilient Networking Services
Deep Medhi · University of Missouri–Kansas City · funded by National Science Foundation
2015–2020 · grant · DP3
Cannula-free and pump-free delivery of insulin using light
Simon H Friedman · University of Missouri–Kansas City · funded by National Institutes of Health
2014–2020 · research · R01
ASSESSING HIV SCREENING IN AFRICAN AMERICAN CHURCHES
Jannette Yvonne Berkley-Patton · University of Missouri–Kansas City · funded by National Institutes of Health
2012–2023 · research · R01
Combination therapy using siRNA nanocompelex and PD-L1 inhibitor for alcoholic liver fibrosis
Kun Cheng · University of Missouri–Kansas City · funded by National Institutes of Health
2012–2022 · training · T32
Cardiovascular Outcomes Research Training Program
John A Spertus · University of Missouri–Kansas City · funded by National Institutes of Health
2012–2022 · training · T32
Cardiovascular Outcomes Research Training Program
John A Spertus · University of Missouri–Kansas City · funded by National Institutes of Health
2012–2023 · research · R01
Combination therapy using siRNA nanocompelex and PD-L1 inhibitor for alcoholic liver fibrosis
Kun Cheng · University of Missouri–Kansas City · funded by National Institutes of Health
2012–2023 · research · R01
Combination therapy using siRNA nanocompelex and PD-L1 inhibitor for alcoholic liver fibrosis
Kun Cheng · University of Missouri–Kansas City · funded by National Institutes of Health
2012–2022 · training · T32
Cardiovascular Outcomes Research Training Program
John A Spertus · University of Missouri–Kansas City · funded by National Institutes of Health
2012–2023 · research · R01
Combination therapy using siRNA nanocompelex and PD-L1 inhibitor for alcoholic liver fibrosis
Kun Cheng · University of Missouri–Kansas City · funded by National Institutes of Health
2012–2027 · training · T32
CARDIOVASCULAR OUTCOMES RESEARCH TRAINING PROGRAM
John A Spertus · University of Missouri–Kansas City · funded by National Institutes of Health
2012–2023 · research · R01
Combination therapy using siRNA nanocompelex and PD-L1 inhibitor for alcoholic liver fibrosis
Kun Cheng · University of Missouri–Kansas City · funded by National Institutes of Health
2012–2023 · research · R01
Combination therapy using siRNA nanocompelex and PD-L1 inhibitor for alcoholic liver fibrosis
Kun Cheng · University of Missouri–Kansas City · funded by National Institutes of Health
2012–2023 · research · R01
Combination therapy using siRNA nanocompelex and PD-L1 inhibitor for alcoholic liver fibrosis
Kun Cheng · University of Missouri–Kansas City · funded by National Institutes of Health
2012–2027 · training · T32
CARDIOVASCULAR OUTCOMES RESEARCH TRAINING PROGRAM
John A Spertus · University of Missouri–Kansas City · funded by National Institutes of Health
2012–2022 · training · T32
Cardiovascular Outcomes Research Training Program
John A Spertus · University of Missouri–Kansas City · funded by National Institutes of Health
2012–2022 · training · T32
Cardiovascular Outcomes Research Training Program
John A Spertus · University of Missouri–Kansas City · funded by National Institutes of Health
2012–2027 · training · T32
CARDIOVASCULAR OUTCOMES RESEARCH TRAINING PROGRAM
John A Spertus · University of Missouri–Kansas City · funded by National Institutes of Health
2012–2027 · training · T32
CARDIOVASCULAR OUTCOMES RESEARCH TRAINING PROGRAM
John A Spertus · University of Missouri–Kansas City · funded by National Institutes of Health
2010–2020 · research · R15
Mechanisms underlying cell-fate patterns in yeast communities
Saul M Honigberg · University of Missouri–Kansas City · funded by National Institutes of Health
2000–2025 · research · R01
Molecular Regulation of Metabotropic Glutamate Receptors in Striatal Neurons
Qiang Wang · University of Missouri–Kansas City · funded by National Institutes of Health
2000–2025 · research · R01
Molecular Regulation of Metabotropic Glutamate Receptors in Striatal Neurons
Qiang Wang · University of Missouri–Kansas City · funded by National Institutes of Health
2000–2026 · research · R01
Molecular Regulation of Metabotropic Glutamate Receptors in Striatal Neurons
Qiang Wang · University of Missouri–Kansas City · funded by National Institutes of Health
2000–2020 · research · R01
Molecular Regulation of Metabotropic Glutamate Receptors in Striatal Neurons
Qiang Wang · University of Missouri–Kansas City · funded by National Institutes of Health
